Rep. Terri A. Sewell Sells GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock

Representative Terri A. Sewell (Democratic-Alabama) recently sold shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC). In a filing disclosed on April 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in GE HealthCare Technologies stock on March 25th.

Representative Terri A. Sewell also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Tapestry (NYSE:TPR) on 3/25/2026.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock opened at $72.26 on Wednesday. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The stock has a market cap of $32.97 billion, a PE ratio of 15.85, a P/E/G ratio of 1.63 and a beta of 1.17. GE HealthCare Technologies Inc. has a 12-month low of $60.75 and a 12-month high of $89.77. The business’s 50-day moving average price is $75.21 and its two-hundred day moving average price is $77.92.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 5 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.07%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on GEHC. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Morgan Stanley boosted their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their price target for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Finally, Citigroup reduced their price target on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a report on Wednesday, March 11th. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $89.77.

Institutional Trading of GE HealthCare Technologies

Institutional investors have recently added to or reduced their stakes in the stock. E Fund Management Hong Kong Co. Ltd. boosted its holdings in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares in the last quarter. Godsey & Gibb Inc. bought a new position in shares of GE HealthCare Technologies during the 3rd quarter worth approximately $26,000. Laurel Wealth Advisors LLC bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $26,000. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. Finally, Godfrey Financial Associates Inc. bought a new position in shares of GE HealthCare Technologies during the 4th quarter worth approximately $27,000. 82.06% of the stock is currently owned by institutional investors.

About Representative Sewell

Terri Sewell (Democratic Party) is a member of the U.S. House, representing Alabama’s 7th Congressional District. She assumed office on January 3, 2011. Her current term ends on January 3, 2027.

Sewell (Democratic Party) is running for re-election to the U.S. House to represent Alabama’s 7th Congressional District. She declared candidacy for the 2026 election.

Below is an abbreviated outline of Sewell’s academic, professional, and political career:

2011-Present: U.S. Representative from Alabama’s 7th Congressional District
1992: Graduated from Harvard University with J.D.
1988: Graduated from Oxford University with M.A.
1986: Graduated from Princeton University with B.A.
Prior to serving in Congress, Sewell was a partner in the Birmingham law office of Maynard, Cooper & Gale, P.C., where she focused on securities and public finance law.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.